Related Experiment Videos
Re: Adverse effect on bone marrow protection of prechemotherapy granulocyte colony-stimulating factor support
Journal of the National Cancer Institute
|March 5, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Sacituzumab govitecan in advanced urothelial carcinoma: TROPiCS-04, a phase III randomized trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
A phase II randomized study of proton therapy vs intensity-modulated radiation therapy in patients with unilateral head and neck cancer.
Journal of the National Cancer Institute·2026
Cancer rarity and mortality: Evidence from a nationwide cohort study.
Journal of the National Cancer Institute·2026
Matched targeted therapy use after broad genomic profiling in advanced Non-Small cell lung cancer.
Journal of the National Cancer Institute·2026
Evaluating the incidence and predictors of chronic opioid use in early survivorship for patients with diffuse large B-cell lymphoma.
Journal of the National Cancer Institute·2026
Predictive validity of a 10-item frailty index based on a comprehensive geriatric assessment (FI-CGA-10) in older Japanese adults with cancer.
Journal of the National Cancer Institute·2026
Association between genomic classifier scores and initial management of localized prostate cancer in the United States.
Journal of the National Cancer Institute·2026